Henley Business Angels invests in Southampton's Renovos Biologics

By Stephen Emerson

24 November 2023

Share

iStock

Five Henley Business Angels members have invested in Renovos Biologics Limited which uses nanotechnology to advance regenerative medicine.

The Oxfordshire-based syndicate said that an ageing population, as well as a more active lifestyle amongst the younger demographics, meant the clinical need for long-term tissue regeneration is growing rapidly.

Renovos Biologics Limited’s solution, RENOVITE®, has unprecedented retention properties, allowing significant dose reduction, lower cost and improved safety of potent drugs.

RENOVITE® is a synthetic, biodegradable nanoclay carrier that can be used to place a wide range of pharmaceutical drugs at the site of treatment across a range of applications, from bone regeneration to wound healing and soft tissue repair.

Dr Agnieszka Janeczek, Founder and CEO of Renovos Biologics Limited, welcomed the investment, explaining they would be using the funding towards "advancing the development of [their] orthobiologics product, RENOVITE® nanoclay, and progressing through regulatory milestones to get this technology closer to clinic and spinal fusion patients.”

By Stephen Emerson

Stephen Emerson is the Managing Editor of The Business Magazine and is responsible for the publication's print publications and online properties including the newly launched Biz News websites in Hampshire and Dorset.

Stephen has been a journalist for 20 years and has worked at local, regional and national publications and led a team which made The Scotsman website one of the fastest growing news sites in the UK with over eight million monthly users.

He has a keen interest in technology, property and corporate finance and telling the stories of the people behind the successful firms in these sectors.